Cervical cancer in India and HPV vaccination

被引：136
作者：
Kaarthigeyan, K. [1 ]
机构：
[1] PSG Inst Med Sci & Res, Dept Pediat, Coimbatore, Tamil Nadu, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2012年 / 33卷 / 01期
关键词：
Cancer; cervix; human papillomavirus; vaccine;
D O I：
10.4103/0971-5851.96961
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cervical cancer, mainly caused by Human Papillomavirus infection, is the leading cancer in Indian women and the second most common cancer in women worldwide. Though there are several methods of prevention of cervical cancer, prevention by vaccination is emerging as the most effective option, with the availability of two vaccines. Several studies have been published examining the vaccine's efficacy, immunogenicity and safety. Questions and controversy remain regarding mandatory vaccination, need for booster doses and cost-effectiveness, particularly in the Indian context.
引用
收藏
页码：7 / 12
页数：6
相关论文
共 28 条
[1]  
American College of Obstetricians and Gynecologists, HPV VACC ACOG REC
[2]  
Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3
[3]   Human papillomavirus and cervical cancer [J].
Burd, EM .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) :1-+
[4]   Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection [J].
Carter, JJ ;
Koutsky, LA ;
Hughes, JP ;
Lee, SK ;
Kuypers, J ;
Kiviat, N ;
Galloway, DA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :1911-1919
[5]  
Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20
[6]  
Choudhury P, 2011, INDIAN PEDIATR, V48, P248
[7]  
Choudhury P, 2010, INDIAN PEDIATR, V47, P724
[8]   Carcinogenicity of human papillomaviruses [J].
Cogliano, V ;
Baan, R ;
Straif, K ;
Grosse, Y ;
Secretan, B ;
El Ghissassi, F .
LANCET ONCOLOGY, 2005, 6 (04) :204-204
[9]   Genital human papillomavirus infection [J].
Dunne, Eileen F. ;
Markowitz, Lauri E. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (05) :624-629
[10]   Cervical-cancer screening beyond the year 2000 [J].
Ferenczy, Alex ;
Franco, Eduardo .
LANCET ONCOLOGY, 2001, 2 (01) :27-32
123